Letteratura

• Cognitive dysfunction and dementia in Parkinson disease. Mov. Disord. 22 (Suppl 17): pp. 358–66.
• Davie CA (2008). A review of Parkinson's disease. Br. Med. Bull. 86 (1): 109–27.
• de Lau LM, Breteler MM (giugno 2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5 (6): 525–35.
• Jankovic J (aprile 2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr. 79 (4): 368–76.
• Limousin, P.; P. Krack; P. Pollak; A. Benazzouz; C. Ardouin; D. Hoffmann; AL. Benabid (ottobre 1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339 (16): 1105-11.
• Madopar. Riassunto delle Caratteristiche del Prodotto. Roche. Aprile 2013.
• Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, et al. (2008). Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov. Disord. 23 (Suppl 3): S548–59.
• Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. (maggio 2010). Missing pieces in the Parkinson's disease puzzle. Nat. Med. 16 (6): 653–61.
• Poewe W (dicembre 2006). The natural history of Parkinson's disease. J. Neurol. 253 (Suppl 7): VII2–6.
• Samii A, Nutt JG, Ransom BR (maggio 2004). Parkinson's disease. Lancet 363 (9423): 1783–93.
• Samuel M. Goldman, et al. "Solvent exposures and Parkinson disease risk in twins" Annals of Neurobiology Volume 71, Issue 6, pages 776–784, June 2012
• Stern, MB. (1991). Head trauma as a risk factor for Parkinson's disease. Mov Disord 6 (2): 95-7.
• Susan B. O'Sullivan, Thomas J. Schmitz, Parkinson's Disease in Physical Rehabilitation, 5th, Philadephia, F.A. Davis, 2007.
• The National Collaborating Centre for Chronic Conditions (a cura di), Symptomatic pharmacological therapy in Parkinson’s disease in Parkinson's Disease, Londra, Royal College of Physicians, 2006, pp. 59–100.